Eramet S.A [ERA] vs ZCI Limited [CV] Detailed Stock Comparison

Eramet S.A
Euronext
Loading...

ZCI Limited
Euronext
Loading...
TLDR: Quick Comparison Summary
We found some data (3 metrics), but not enough for a complete comparison. Metrics like P/E ratio, profitability, and financial health are still available in the detailed tabs below.
View Metrics Details
Vital Metrics Comparison
Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.
Metric | Eramet S.A | ZCI Limited | Better |
---|---|---|---|
P/E Ratio (TTM) | 105.50 | 2.50 | ZCI Limited |
Price-to-Book Ratio | 1.34 | N/A | N/A |
Debt-to-Equity Ratio | 140.34 | N/A | N/A |
PEG Ratio | 5.00 | N/A | N/A |
EV/EBITDA | 15.26 | N/A | N/A |
Profit Margin (TTM) | -3.33% | N/A | N/A |
Operating Margin (TTM) | -6.81% | N/A | N/A |
Return on Equity | -6.50% | N/A | N/A |
Return on Assets (TTM) | -0.09% | N/A | N/A |
Free Cash Flow (TTM) | $-812.00M | N/A | N/A |
Dividend Yield | 3.15% | N/A | N/A |
1-Year Return | -28.52% | 0.00% | ZCI Limited |
Price-to-Sales Ratio (TTM) | 0.48 | N/A | N/A |
Enterprise Value | $3.83B | $0 | Eramet S.A |
EV/Revenue Ratio | 1.31 | N/A | N/A |
Revenue per Share (TTM) | $102 | N/A | N/A |
Earnings per Share (Diluted) | $-3.37 | N/A | N/A |
Beta (Stock Volatility) | 1.53 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Eramet S.A vs ZCI Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Eramet S.A | 0.94% | 3.58% | 3.71% | -2.79% | -14.02% | -10.49% |
ZCI Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Eramet S.A | -28.52% | -52.29% | 80.93% | -11.92% | -42.78% | -42.78% |
ZCI Limited | 0.00% | 0.00% | 0.00% | 0.00% | -31.03% | -31.03% |
Performance & Financial Health Analysis: Eramet S.A vs ZCI Limited
Metric | ERA | CV |
---|---|---|
Market Information | ||
Market Cap | €1.40B | €11.14M |
Market Cap Category | Large cap | Small cap |
10 Day Avg. Volume | 57,089 | N/A |
90 Day Avg. Volume | 49,073 | N/A |
Last Close | €49.14 | €0.20 |
52 Week Range | €38.74 - €74.70 | €0.20 - €0.20 |
% from 52W High | -34.22% | 0.00% |
All-Time High | €167.20 (Apr 16, 2018) | €0.29 (Jul 14, 2014) |
% from All-Time High | -70.61% | -31.03% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.07% | N/A |
Quarterly Earnings Growth | N/A | N/A |
Financial Health | ||
Profit Margin (TTM) | -0.03% | N/A |
Operating Margin (TTM) | -0.07% | N/A |
Return on Equity (TTM) | -0.07% | N/A |
Debt to Equity (MRQ) | 140.34 | N/A |
Cash & Liquidity | ||
Book Value per Share (MRQ) | €36.47 | N/A |
Cash per Share (MRQ) | €26.06 | N/A |
Operating Cash Flow (TTM) | €-133,000,000 | €0 |
Levered Free Cash Flow (TTM) | €-493,624,992 | €0 |
Dividends | ||
Last 12-Month Dividend Yield | 3.15% | N/A |
Last 12-Month Dividend | €1.51 | N/A |
Valuation & Enterprise Metrics Analysis: Eramet S.A vs ZCI Limited
Metric | ERA | CV |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 105.50 | 2.50 |
Forward P/E | 5.00 | N/A |
PEG Ratio | 5.00 | N/A |
Price to Sales (TTM) | 0.48 | N/A |
Price to Book (MRQ) | 1.34 | N/A |
Market Capitalization | ||
Market Capitalization | €1.40B | €11.14M |
Enterprise Value | €3.83B | €0 |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.31 | N/A |
Enterprise to EBITDA | 15.26 | N/A |
Risk & Other Metrics | ||
Beta | 1.53 | N/A |
Book Value per Share (MRQ) | €36.47 | N/A |
Financial Statements Comparison: Eramet S.A vs ZCI Limited
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ERA | CV |
---|---|---|
Revenue/Sales | N/A | N/A |
Cost of Goods Sold | N/A | N/A |
Gross Profit | N/A | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | N/A |
EBITDA | N/A | N/A |
Pre-Tax Income | N/A | N/A |
Income Tax | N/A | N/A |
Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ERA | CV |
---|---|---|
Cash & Equivalents | N/A | N/A |
Total Current Assets | N/A | N/A |
Total Current Liabilities | N/A | N/A |
Long-Term Debt | €1.88B | N/A |
Total Shareholders Equity | €1.44B | N/A |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | €-802.00M | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ERA | CV |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ERA | CV |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 57,089 | N/A |
Average Daily Volume (90 Day) | 49,073 | N/A |
Shares Outstanding | 28.58M | 55.68M |
Float Shares | 9.39M | N/A |
% Held by Insiders | 0.70% | N/A |
% Held by Institutions | 0.12% | N/A |
Dividend Analysis & Yield Comparison: Eramet S.A vs ZCI Limited
Metric | ERA | CV |
---|---|---|
Last 12-Month Dividend | €1.51 | N/A |
Last 12-Month Dividend Yield | 3.15% | N/A |
3-Year Avg Annual Dividend | €2.17 | N/A |
3-Year Avg Dividend Yield | 2.79% | N/A |
3-Year Total Dividends | €6.51 | N/A |
Ex-Dividend Date | Jun 02, 2025 | N/A |